A new report from the Centers of Disease Control and Prevention (CDC) indicates China may be facing a healthcare crisis with an steep rise in the number of cases involving drug-resistant sexually-transmitted disease . . . including “super-gonorrhea.”

Up to 98 percent of bacteria samples taken from patients with the STD across 13 Chinese provinces had the ability to sidestep frontline antibiotics, according to a new CDC report.

Gonorrhea had been effectively evading medications for years, but the chief worry among researchers is that China is reporting rates of a strain resistant to one of the last remaining effective antibiotics 40 times higher than those in the US, UK, and Canada.

Gonorrhea-causing bacteria have excelled at working around antibiotics, so much so that the only remaining recommended treatment is ceftriaxone.